期刊文献+

分析高血压合并糖尿病患者接受替米沙坦+卡维地洛联合治疗的降压效果及对糖代谢的影响 被引量:3

To analyze the antihypertensive effect of telmisartan combined with carvedilol in hypertensive patients with diabetes mellitus and its effect on glucose metabolism
下载PDF
导出
摘要 目的:分析高血压合并糖尿病患者接受替米沙坦+卡维地洛联合治疗的降压效果及对糖代谢的影响。方法:2018年10月-2020年6月收治高血压合并糖尿病患者96例,随机分为两组,各48例。观察组给予替米沙坦联合卡维地洛治疗,参照组给予吲达帕胺联合卡维地洛治疗,比较两组治疗效果。结果:观察组收缩压及舒张压水平均显著低于参照组,差异有统计学意义(P<0.05);观察组餐后2 h血糖(PPG)、空腹胰岛素(FIns)及餐后2 h胰岛素(2 hFIns)水平均显著低于参照组,差异有统计学意义(P<0.05)。结论:在高血压合并糖尿病患者的治疗中联合应用替米沙坦和卡维地洛,对控制血压水平以及改善糖代谢指标水平均有非常显著的效果。 Objective:To analyze the antihypertensive effect of telmisartan combined with carvedilol in hypertensive patients with diabetes mellitus and its effect on glucose metabolism.Methods:From October 2018 to June 2020,96 patients with hypertension and diabetes were selected.They were randomly divided into two groups with 48 cases in each group.The observation group was treated with telmisartan combined with carvedilol.The control group was treated with indapamide combined with carvedilol.We compared the therapeutic effects of the two groups.Results:In the observation group,the average systolic blood pressure and diastolic blood pressure were significantly lower than those in the reference group,the difference was statistically significant(P<0.05).In the observation group,the levels of postprandial 2 h blood glucose(PPG),fasting insulin(FIns)and postprandial 2-h insulin(2 hFIns)were significantly lower than those in the reference group,the difference was statistically significant(P<0.05).Conclusion:In the treatment of hypertension complicated with diabetes mellitus,the combination of telmisartan and carvedilol has a very significant effect on controlling blood pressure and improving glucose metabolism.
作者 郭军霞 Guo Junxia(Department of Geriatrics,the People's Hospital of Zezhou County,Shanxi Jincheng 048000)
出处 《中国社区医师》 2021年第33期24-25,共2页 Chinese Community Doctors
关键词 高血压合并糖尿病 替米沙坦 卡维地洛 糖代谢 Hypertension complicated with diabetes mellitus Telmisartan Carvedilol Glucose metabolism
  • 相关文献

参考文献5

二级参考文献36

  • 1李立明,饶克勤,孔灵芝,姚崇华,向红丁,翟凤英,马冠生,杨晓光,中国居民营养与健康状况调查技术执行组.中国居民2002年营养与健康状况调查[J].中华流行病学杂志,2005,26(7):478-484. 被引量:1782
  • 2全国血压抽样调查协作组.中国高血压的患病率、知晓率及治疗和控制状况:1991年抽样调查结果[J].高血压杂志,1995,3(A01):14-18. 被引量:199
  • 3全国血压抽样调查协作组.中国人群高血压患病率及其变化趋势[J].高血压杂志,1995,3(A01):7-13. 被引量:508
  • 4周北凡.90年代初期我国心血管病的总体形势和特点[J].中国慢性病预防与控制,1996,4:145-149.
  • 5Kearney PM, Wheltnn M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet, 2005, 365: 217-223.
  • 6Wu YF, Huxley R, Li LM, et al. Prevalence, awareness, treatment, and control of hypertension in China-data from the China national nutrition and health survey 2002. Circulation, 2008,118:2679-2686.
  • 7Ezzati M, Lopez AD, Rodgers A, et al. Selected major risk factors and global and regional burden of disease. Lancet, 2002, 360: 1347-1360.
  • 8Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet ,2002,360 : 1903-1913.
  • 9Frazier CG, Shah SI-I, Armstrong PW, et al. Prevalence and management of hypertension in acute coronary syndrome patients varies by sex: observations from the sibrafiban versus aspirin to yield maximum protection from ischemic heart events postacute cocoNary syndromes (SYMPHONY) randomized clinical trials. Am Heart J, 2005,150 : 1260-1267.
  • 10Nathan DW, Gaurav Thakral, Stanley SF, et al. Preventing heart disease by controlling hypertension: impact of hypertensive subtype, stage, age, and sex. Am Heart J, 2003,145:888-895.

共引文献165

同被引文献24

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部